The PASTDUe Nutrition Ecosystem Project (PASTDUe)
PASTDUe
The PASTDUe Nutrition EcoSystem Pathway In Acute Care Abdominal Surgery and Trauma to Decrease Underfeeding and Complications
1 other identifier
interventional
300
1 country
1
Brief Summary
This is a research study to determine if a particular method of providing nutrition improves the clinical outcomes of patients in the intensive care unit (ICU) who have undergone abdominal surgery and would require nutrition delivered via the bloodstream (called total parenteral nutrition or TPN). The nutrition method we are testing is a structured nutrition delivery plan that involves tube feeding, oral nutrition supplements, and the use of a device (called an indirect calorimeter or IC) to measure calorie needs. This study will also use two devices to measure fat and muscle mass to examine changes during hospitalization. Subjects will be followed throughout hospitalization where nutrition status and fat and muscle mass will be closely monitored. Study activities will begin within 72 hours of a patient's abdominal surgery. TPN (total parenteral nutrition, a method of feeding that bypasses the usual process of eating and digestion) will be started, a non-invasive method of assessing calorie needs (indirect calorimetry (IC)) will be started, a urine sample will be collected to help assist in protein needs, and fat/muscle mass will be measured using bioelectrical impedance analysis (BIA), and an ultrasound. This is a minimal risk study and all products/devices used are non-invasive and FDA-approved. Indirect calorimetry and urine sample collection will be conducted every 3 days during the stay in the Intensive Care Unit - ICU, then every 5 days until hospital discharge. BIA and muscle ultrasound will be conducted every 7 days during ICU stay, then every 14 days until hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Apr 2022
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2021
CompletedFirst Posted
Study publicly available on registry
November 19, 2021
CompletedStudy Start
First participant enrolled
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2027
ExpectedApril 23, 2026
January 1, 2026
3.8 years
November 9, 2021
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Number of nosocomial infection complications as measured by medical record review
From TPN initiation, daily until hospital discharge (up to 8 months)
ICU length of stay in days measured by medical record review
From TPN initiation, daily until hospital discharge (up to 8 months)
Secondary Outcomes (11)
Incidence of protein-calorie malnutrition measured using AND/ASPEN-defined malnutrition criteria
Measured daily from hospital admission to hospital discharge (up to 8 months)
Number of days patient is on ventilator measured by medical record review
Measured daily from hospital admission up to hospital discharge (up to 8 months)
Number of patients discharged home measured by medical record review/patient report
Recorded at hospital discharge (up to 8 months)]
Number of patients discharged to rehabilitation center measured by medical record review/patient report
Recorded at hospital discharge (up to 8 months)]
Number of patients discharged to nursing home measured by medical record review/patient report
Recorded at hospital discharge (up to 8 months)]
- +6 more secondary outcomes
Study Arms (2)
Nutrition Ecosystem pathway
EXPERIMENTAL1. parenteral nutrition initiated within 72 hours of operative intervention 2. metabolic cart assessments to determine resting energy expenditure (REE) and guide registered dietitians (RDs) 3. expedited delivery of oral nutrition supplements and 4. a team-based approach on proper documentation of nutrition delivery and intake.
Comparator
OTHER300 historical matched control subjects not having received TPN in the first 7 hospital days will be enrolled from Duke Electronic Health Record between January 2018 and June 2020.
Interventions
1. parenteral nutrition initiated within 72 hours of operative intervention * Provided as clinically appropriate: Ensure Enlive, Ensure High-Protein, Nepro with Carb-Steady/ProSource Gelatein Plus, and/or ProSource Gelatein Plus 2. metabolic cart assessments to determine resting energy expenditure (REE) and guide registered dietitians (RDs) * Q-NRG Metabolic Cart (Indirect Calorimeter) and Quark RMR Metabolic Cart (Indirect Calorimeter) * BWA 2.0 Advanced Bioelectric Impedance Spectroscopy (BIS) * Philips Lumify L12-4 broadband linear array transducer ultrasound 3. expedited delivery of oral nutrition supplements and 4. a team-based approach on proper documentation of nutrition delivery and intake
Eligibility Criteria
You may qualify if:
- Age \>= 18 years
- ICU admission with major abdominal trauma, intra-abdominal sepsis, ischemic bowel/vascular emergencies, or penetrating trauma
- Not expected to receive oral or enteral nutrition for \> 72 hours
- Primary team approval of PN
- \. \< 72 hours post-operative intervention
You may not qualify if:
- Expected death or withdrawal of life-sustaining treatment within the first 72 hours of ICU admission
- Patients admitted with
- Diabetic ketoacidosis or non-ketotic hyperosmolar coma
- MELD \> 20 or acute fulminant hepatic failure
- Patients allergic to any component of parenteral nutrition or lipid solution
- Pregnant or breastfeeding patients
- Incarcerated or prisoner prior to admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Wischmeyer
Duke University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2021
First Posted
November 19, 2021
Study Start
April 25, 2022
Primary Completion
February 20, 2026
Study Completion (Estimated)
February 20, 2027
Last Updated
April 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share